- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 403/00 - Derivatives of cyclohexane or of a cyclohexene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene rings, e.g. vitamin A, beta-carotene, beta-ionone
Patent holdings for IPC class C07C 403/00
Total number of patents in this class: 35
10-year publication summary
5
|
4
|
1
|
1
|
0
|
1
|
1
|
0
|
1
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
DSM IP Assets B.V. | 5669 |
6 |
BASF SE | 20666 |
2 |
Uop LLC | 4211 |
2 |
PTC Therapeutics, Inc. | 468 |
2 |
Ramot at Tel-Aviv University Ltd. | 1463 |
2 |
Glaxosmithkline LLC | 538 |
1 |
Bayer Intellectual Property GmbH | 2536 |
1 |
The United States of America as represented by the Secretary of the Navy | 2731 |
1 |
Albany Molecular Research, Inc. | 64 |
1 |
Anhui Medical University | 20 |
1 |
Anhui New Star Pharmaceutical Development Co., Ltd. | 13 |
1 |
Bioxell S.p.A. | 8 |
1 |
The Board of Regents of the University of Oklahoma | 603 |
1 |
Cabio Biotech (Wuhan) Co., Ltd. | 26 |
1 |
Department of Biotechnology | 70 |
1 |
Florida Atlantic University | 61 |
1 |
The Government of the United States of America, as represented by the Secretary of the Navy | 1271 |
1 |
National Brain Research Centre | 9 |
1 |
National University Corporation Nara Institute of Science and Technology | 245 |
1 |
OmniActive Health Technologies Limited | 114 |
1 |
Other owners | 6 |